Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials
Joe N. Kornegay(Texas A&M University), K. Nagaraju(National Institutes of Health), C. F. Spurney, Candice Brinkmeyer‐Langford, Peter P. Nghiem(Texas A&M University), Eric P. Hoffman(Binghamton University)
Cited by 52
Related Papers
Expression Profiling in the Muscular Dystrophies
|The Journal of Cell Biology|2000|481
Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.
|PubMed|1991|401
Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans
|Cell Metabolism|2005|391